Abbott s new global diagnostics coalition focuses on future pandemic preparedness
Abbott s new global diagnostics coalition focuses on future pandemic preparedness
Kelsy Ketchum, 360Dx
Print
Although the pandemic isn t over yet, the question of future pandemics is still on the mind of many infectious disease experts.
With that in mind, Abbott is using its infectious disease experience, building on its Global Viral Surveillance Program for HIV and viral hepatitis research, to spearhead a coalition that will prepare for disease outbreaks, particularly those that haven t yet happened and pathogens that have yet to be discovered.
According to Gavin Cloherty, the head of infectious disease research at Abbott, the Abbott Pandemic Defense Coalition is the culmination of several years of preparation that has grown from the global surveillance program.
Loading video.
VIDEO: What happened in the tropics when an asteroid hit the planet and how did it shape today s rainforests? view more
Credit: Monica Carvalho
Tropical rainforests today are biodiversity hotspots and play an important role in the world s climate systems. A new study published today in
Science sheds light on the origins of modern rainforests and may help scientists understand how rainforests will respond to a rapidly changing climate in the future.
The study led by researchers at the Smithsonian Tropical Research Institute (STRI) shows that the asteroid impact that ended the reign of dinosaurs 66 million years ago also caused 45% of plants in what is now Colombia to go extinct, and it made way for the reign of flowering plants in modern tropical rainforests.
Abbott Pandemic Defence Coalition aims to identify new viral threats and take quick action news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Covid Hit These Countries Hard. Now They Face Big Vaccine Bills
Bloomberg 3/16/2021 James Paton and Andrea Jaramillo
(Bloomberg) Colombia has already paid a steep price in the pandemic with more than 61,000 deaths from Covid-19. Now the South American nation faces another cost: about $850 million to immunize its population.
Popular Searches
South Africa, Colombia and other middle-income countries hit hard by Covid have lined up behind richer ones to buy vaccines in hopes of averting more suffering. They’ve pursued cheaper doses from AstraZeneca Plc, as well as far more expensive shots from Moderna Inc.
With an annual health budget of just $10 billion for about 50 million residents, Colombia is one of many countries struggling to afford those immunizations. Health-care advocates have said that drugmakers have the upper hand in negotiations with governments that have limited cash and aren’t eligible for free doses. Emerging details show the extent of the
South Africa among countries left with a massive bill from fighting for Covid vaccine scraps
Bloomberg16 March 2021
Subscribe
Colombia has already paid a steep price in the pandemic with more than 61,000 deaths from Covid-19. Now the South American nation faces another cost: about $850 million to immunise its population.
South Africa, Colombia and other middle-income countries hit hard by Covid have lined up behind richer ones to buy vaccines in hopes of averting more suffering. They’ve pursued cheaper doses from AstraZeneca Plc, as well as far more expensive shots from Moderna Inc.
With an annual health budget of just $10 billion for about 50 million residents, Colombia is one of many countries struggling to afford those immunisations. Health-care advocates have said that drugmakers have the upper hand in negotiations with governments that have limited cash and aren’t eligible for free doses. Emerging details show the extent of the squeeze.